Affineti Biologics

Affineti Biologics is a biotechnology company dedicated to the discovery and development of next-generation multi-specific antibodies. The company leverages a proprietary closed-loop platform that integrates generative artificial intelligence and machine learning with high-throughput experimental biology. This approach allows for the rapid design and optimization of complex biologics that can address challenging disease targets in oncology and immunology. By engineering molecules capable of engaging multiple pathways simultaneously, Affineti aims to create more effective therapies for patients with limited treatment options. Headquartered in Menlo Park, California, the firm was founded by industry experts with significant experience in AI-driven protein engineering.